– UK, London – MiNA Therapeutics, the pioneer in RNA activation therapeutics, today announced the completion of a £23 million Series A equity financing led by aMoon, Israel’s largest healthtech and life sciences venture fund, with participation from existing investors.…
DayTwo adds John Watts Jr. to its Board of Directors and announces Dave Henderson joining as CEO along with raising $37m new funding
– USA, CA – DayTwo, the leader in precision nutrition with the world’s most advanced proprietary microbiome science, today announced the appointment of David Henderson, a former founding executive member of Oscar Health, as CEO.…